Hospitals operator Fortis Healthcare (India) Limited said it paid S$62.9 million ($50.09 million) to buy 85 per cent in RadLink-Asia Pte Ltd, a Singapore-based diagnostic chain, sending Fortis shares up near 4% in Mumbai market. RadLink-Asia will provide diagnostic platform for Fortis Healthcare’s new specialty hospital coming up in Singapore, apart from giving the Indian hospital operator an entry into the premium diagnostics and molecular imaging market there.